Reply to Letter to the Editor "Long-term outcomes in the PRIMA trial: a closer look at PFS and OS" by Wu et al

Ann Oncol. 2024 Dec 6:S0923-7534(24)04955-X. doi: 10.1016/j.annonc.2024.12.001. Online ahead of print.

Authors

A González-Martín¹, I A Malinowska², B J Monk³

Affiliations

¹ Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid; Grupo Español de Investigación en Cancer ginecológicO (GEICO), Madrid, Spain. Electronic address: [email protected].
² GSK, Waltham.
³ GOG Foundation, Philadelphia; Florida Cancer Specialists and Research Institute, West Palm Beach, USA.

PMID: 39647780
DOI: 10.1016/j.annonc.2024.12.001

No abstract available

Publication types

Letter